Maravai LifeSciences (MRVI): Price and Financial Metrics

Maravai LifeSciences (MRVI): $14.50

0.61 (+4.39%)

POWR Rating

Component Grades













Add MRVI to Watchlist
Sign Up

Industry: Biotech



in industry


  • Quality is the dimension where MRVI ranks best; there it ranks ahead of 89.97% of US stocks.
  • MRVI's strongest trending metric is Stability; it's been moving down over the last 177 days.
  • MRVI's current lowest rank is in the Growth metric (where it is better than 8.41% of US stocks).

MRVI Stock Summary

  • MRVI's went public 2.19 years ago, making it older than just 10.14% of listed US stocks we're tracking.
  • MRVI's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 80.75% of US stocks.
  • The volatility of MARAVAI LIFESCIENCES HOLDINGS INC's share price is greater than that of 85.24% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to MARAVAI LIFESCIENCES HOLDINGS INC, a group of peers worth examining would be APEN, PHUN, FTK, EKSO, and ECOR.
  • MRVI's SEC filings can be seen here. And to visit MARAVAI LIFESCIENCES HOLDINGS INC's official web site, go to

MRVI Valuation Summary

  • MRVI's price/earnings ratio is 15.1; this is 33.48% lower than that of the median Healthcare stock.
  • Over the past 26 months, MRVI's price/earnings ratio has gone up 1736.9.

Below are key valuation metrics over time for MRVI.

Stock Date P/S P/B P/E EV/EBIT
MRVI 2023-01-20 4.0 7.1 15.1 10.8
MRVI 2023-01-19 3.9 7.1 15.0 10.8
MRVI 2023-01-18 3.9 7.1 15.0 10.8
MRVI 2023-01-17 3.9 7.0 14.8 10.6
MRVI 2023-01-13 3.9 7.0 14.8 10.7
MRVI 2023-01-12 3.9 7.0 14.8 10.6

MRVI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MRVI has a Quality Grade of C, ranking ahead of 71.9% of graded US stocks.
  • MRVI's asset turnover comes in at 0.307 -- ranking 150th of 682 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows MRVI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.307 0.72 0.155

MRVI Price Target

For more insight on analysts targets of MRVI, see our MRVI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $49.33 Average Broker Recommendation 1.22 (Strong Buy)

MRVI Stock Price Chart Interactive Chart >

Price chart for MRVI

MRVI Price/Volume Stats

Current price $14.50 52-week high $41.82
Prev. close $13.89 52-week low $12.16
Day low $13.73 Volume 1,101,800
Day high $14.76 Avg. volume 1,594,633
50-day MA $14.00 Dividend yield N/A
200-day MA $22.80 Market Cap 3.70B

Maravai LifeSciences (MRVI) Company Bio

Maravai Lifesciences Holdings, Inc. operates as an investment holding company. It develops biopharmaceuticals. The company is headquartered in San Diego, CA.

MRVI Latest News Stream

Event/Time News Detail
Loading, please wait...

MRVI Latest Social Stream

Loading social stream, please wait...

View Full MRVI Social Stream

Latest MRVI News From Around the Web

Below are the latest news stories about MARAVAI LIFESCIENCES HOLDINGS INC that investors may wish to consider to help them evaluate MRVI as an investment opportunity.

3 Biopharma Stocks That Could Help Make You a Fortune

As any biotech investor will tell you freely, investing in biopharma is rife with risks. Clinical trials can miss the mark, and successful medicines on the market can get outcompeted by newer entrants. To do that, they tend to have a mix of reliable sales alongside a bunch of ambitious projects to provide upside.

Yahoo | January 16, 2023

Do you want to know where to find good stock? Take a look at Maravai LifeSciences Holdings Inc.’s (NASDAQ:MRVI) Sentiment Analysis

Maravai LifeSciences Holdings Inc. (MRVI)’s stock has witnessed a price declined of -6.44% from the previous close with its current price standing at $13.08. Its current price is -68.72% under its 52-week high of $41.82 and 7.57% more than its 52-week low of $12.16. Based on the past 30-day period, the stock price is -14.82% […]

US Post News | January 5, 2023

Maravai LifeSciences Holdings: A Tough Year Or Two Ahead (NASDAQ:MRVI)

Maravai LifeSciences looks like it''s going to underperform in 2023, and probably beyond that. Click here to read my analysis of MRVI stock.

Seeking Alpha | January 5, 2023

Maravai LifeSciences downgraded to neutral at UBS on lack of near-term catalyst (MRVI)

UBS has downgraded Maravai LifeSciences (MRVI) to neutral from buy as 2023 will likely be a transition year.

Seeking Alpha | January 5, 2023

Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI): Blank Check On Growth?

Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) price on Wednesday, December 21, fall -0.70% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.12. A look at the stock’s price movement, the close in the last trading session was $14.22, moving within a range at $14.00 and $14.67. The PE … Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI): Blank Check On Growth? Read More »

Stocks Register | December 22, 2022

Read More 'MRVI' Stories Here

MRVI Price Returns

1-mo 2.84%
3-mo -13.28%
6-mo -43.29%
1-year -46.89%
3-year N/A
5-year N/A
YTD 1.33%
2022 -65.85%
2021 49.38%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 7.8844 seconds.